Skip to main content
SpringerLink
Log in

Adenosine and Regadenoson Stress Echocardiography

  • Chapter
Stress Echocardiography

  • 1493 Accesses

Abstract

Various pharmacologic stress agents are currently available, including adenosine, dipyridamole, and most recently regadenoson. These agents have a common mechanism, mediated through activation (nonselective or selective) of adenosine A2A receptors with resultant coronary vasodilation. Adenosine and dipyridamole have been the mainstays of vasodilator myocardial perfusion imaging (MPI) for almost two decades [1]. Radionuclide scintigraphy [2], positron emission tomography [3], and magnetic resonance imaging [4] have been the modalities traditionally utilized for myocardial perfusion imaging. Adenosine stress testing is a procedure in which patients are exposed to an intravenous infusion of adenosine while simultaneous monitoring of symptoms, hemodynamic parameters, electrocardiogram, and imaging occurs [5]. Adenosine is a second-generation vasodilator adenosinergic stress agent, evolving from the first-generation prototype, dipyridamole, which acts by triggering accumulation of endogenous adenosine [6] ( Table 14.1). Perfusion imaging with scintigraphy is the dominant application of adenosine stress testing with up to 63 % of overall perfusion studies performed with adenosine and 30 % with dipyridamole in the USA [7]. The 2009 update of the American Society of Nuclear Cardiology guidelines for nuclear cardiology procedures illustrates the different protocols in place for these vasodilator agents [8].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 199.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Shryock JC, Belardinelli L (1997) Adenosine and adenosine receptors in the cardiovascular system: biochemistry, physiology, and pharmacology. Am J Cardiol 79(12A):2–10

    Article  CAS  PubMed  Google Scholar 

  2. Verani MS (1991) Adenosine thallium 201 myocardial perfusion scintigraphy. Am Heart J 122(1 Pt 1):269–278; discussion 302–366

    Article  CAS  PubMed  Google Scholar 

  3. Bateman TM (2004) Cardiac positron emission tomography and the role of adenosine pharmacologic stress. Am J Cardiol 94(2A):19D–24D. doi:10.1016/j.amjcard.2004.04.013; discussion 24D–25D

    Article  PubMed  Google Scholar 

  4. Paetsch I, Jahnke C, Wahl A et al (2004) Comparison of dobutamine stress magnetic resonance, adenosine stress magnetic resonance, and adenosine stress magnetic resonance perfusion. Circulation 110:835–842. doi:10.1161/01.CIR.0000138927.00357.FB

    Article  CAS  PubMed  Google Scholar 

  5. Verani MS, Mahmarian JJ, Hixson JB, Boyce TM, Staudacher RA (1990) Diagnosis of coronary artery disease by controlled coronary vasodilation with adenosine and thallium-201 scintigraphy in patients unable to exercise. Circulation 82:80–87

    Article  CAS  PubMed  Google Scholar 

  6. Picano E (1989) Dipyridamole-echocardiography test: historical background and physiologic basis. Eur Heart J 10:365–376

    CAS  PubMed  Google Scholar 

  7. Arlington Medical Resources (2006) The myocardial perfusion market guide (US and Europe). Arlington Medical Resources, Arlington

    Google Scholar 

  8. Henzlova MJ, Cerqueira MD, Hansen CL, Taillefer R, Yao S (2009) ASNC imaging guidelines for nuclear cardiology procedures – stress protocols and tracers. Am Soc Nucl Cardiol. Available at: www.asnc.org under Guidelines and Standards

  9. Zoghbi WA (1991) Use of adenosine echocardiography for diagnosis of coronary artery disease. Am Heart J 122(1 Pt 1):285–292; discussion 302–386

    Article  CAS  PubMed  Google Scholar 

  10. Djordjevic-Dikic AD, Ostojic MC, Beleslin BD et al (1996) High dose adenosine stress echocardiography for noninvasive detection of coronary artery disease. J Am Coll Cardiol 28:1689–1695. doi:10.1016/S0735-1097(96)00374-9

    Article  CAS  PubMed  Google Scholar 

  11. Lafitte S, Masugata H, Peters B et al (2001) Accuracy and reproducibility of coronary flow rate assessment by real-time contrast echocardiography: in vitro and in vivo studies. J Am Soc Echocardiogr 14:1010–1019

    Article  CAS  PubMed  Google Scholar 

  12. Mulvagh SL, Rakowski H, Vannan MA et al (2008) American Society of Echocardiography Consensus Statement on the Clinical Applications of Ultrasonic Contrast Agents in Echocardiography. J Am Soc Echocardiogr 21:1179–1201. doi:10.1016/j.echo.2008.09.009; quiz 1281

    Article  PubMed  Google Scholar 

  13. Caiati C, Zedda N, Montaldo C, Montisci R, Iliceto S (1999) Contrast-enhanced transthoracic second harmonic echo Doppler with adenosine: a noninvasive, rapid and effective method for coronary flow reserve assessment. J Am Coll Cardiol 34:122–130

    Article  CAS  PubMed  Google Scholar 

  14. Sicari R, Nihoyannopoulos P, Evangelista A et al (2009) Stress Echocardiography Expert Consensus Statement–Executive Summary: European Association of Echocardiography (EAE) (a registered branch of the ESC). Eur Heart J 30:278–289. doi:10.1093/eurheartj/ehn492

    Article  PubMed  Google Scholar 

  15. Korosoglou G, Dubart AE, DaSilva KG Jr et al (2006) Real-time myocardial perfusion imaging for pharmacologic stress testing: added value to single photon emission computed tomography. Am Heart J 151:131–138. doi:10.1016/j.ahj.2005.02.046

    Article  PubMed  Google Scholar 

  16. Cerqueira MD (2004) The future of pharmacologic stress: selective A2A adenosine receptor agonists. Am J Cardiol 94(2A):33D–40D. doi:10.1016/j.amjcard.2004.04.017; discussion 40D–42D

    Article  CAS  PubMed  Google Scholar 

  17. Iskandrian AE, Bateman TM, Belardinelli L et al (2007) Adenosine versus regadenoson comparative evaluation in myocardial perfusion imaging: results of the ADVANCE phase 3 multicenter international trial. J Nucl Cardiol 14:645–658. doi:10.1016/j.nuclcard.2007.06.114

    Article  PubMed  Google Scholar 

  18. Lexiscan (2008) (regadenoson injection) package insert. Astellas Pharma, US, Inc, Deerfield

    Google Scholar 

  19. Mahmarian JJ, Cerqueira MD, Iskandrian AE et al (2009) Regadenoson induces comparable left ventricular perfusion defects as adenosine: a quantitative analysis from the ADVANCE MPI 2 trial. JACC Cardiovasc Imaging 2:959–968. doi:10.1016/j.jcmg.2009.04.011

    Article  PubMed  Google Scholar 

  20. Fredholm BB, Abbracchio MP, Burnstock G et al (1994) Nomenclature and classification of purinoceptors. Pharmacol Rev 46:143–156

    CAS  PubMed  Google Scholar 

  21. Drury AN, Szent-Gyorgyi A (1929) The physiological activity of adenine compounds with especial reference to their action upon the mammalian heart. J Physiol 68:213–237

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  22. MacCollin M, Peterfreund R, MacDonald M, Fink JS, Gusella J (1994) Mapping of a human A2a adenosine receptor (ADORA2) to chromosome 22. Genomics 20:332–333. doi:10.1006/geno.1994.1181

    Article  CAS  PubMed  Google Scholar 

  23. Andreassi MG, Laghi Pasini F, Picano E et al (2011) Adenosine A2(A) receptor gene polymorphism (1976C > T) affects coronary flow reserve response during vasodilator stress testing in patients with non ischemic-dilated cardiomyopathy. Pharmacogenet Genomics 21:469–475. doi:10.1097/FPC.0b013e328347d2c6

    Article  CAS  PubMed  Google Scholar 

  24. Jacobson KA (2009) Introduction to adenosine receptors as therapeutic targets. Handb Exp Pharmacol 193:1–24. doi:10.1007/978-3-540-89615-9_1

    Article  CAS  PubMed  Google Scholar 

  25. Conradson TB, Dixon CM, Clarke B, Barnes PJ (1987) Cardiovascular effects of infused adenosine in man: potentiation by dipyridamole. Acta Physiol Scand 129:387–391. doi:10.1111/j.1748-1716.1987.tb08082.x

    Article  CAS  PubMed  Google Scholar 

  26. Biaggioni I, Olafsson B, Robertson RM, Hollister AS, Robertson D (1987) Cardiovascular and respiratory effects of adenosine in conscious man. Evidence for chemoreceptor activation. Circ Res 61:779–786

    Article  CAS  PubMed  Google Scholar 

  27. Iskandrian AS, Verani MS, Heo J (1994) Pharmacologic stress testing: mechanism of action, hemodynamic responses, and results in detection of coronary artery disease. J Nucl Cardiol 1:94–111

    Article  CAS  PubMed  Google Scholar 

  28. Beleslin BD, Ostojic M, Djordjevic-Dikic A et al (1997) Coronary vasodilation without myocardial erection. Simultaneous haemodynamic, echocardiographic and arteriographic findings during adenosine and dipyridamole infusion. Eur Heart J 18:1166–1174

    Article  CAS  PubMed  Google Scholar 

  29. Trochu JN, Zhao G, Post H et al (2003) Selective A2A adenosine receptor agonist as a coronary vasodilator in conscious dogs: potential for use in myocardial perfusion imaging. J Cardiovasc Pharmacol 41:132–139

    Article  CAS  PubMed  Google Scholar 

  30. Dhalla AK, Wong MY, Wang WQ, Biaggioni I, Belardinelli L (2006) Tachycardia caused by A2A adenosine receptor agonists is mediated by direct sympathoexcitation in awake rats. J Pharmacol Exp Ther 316:695–702. doi:10.1124/jpet.105.095323

    Article  CAS  PubMed  Google Scholar 

  31. Thomas GS, Tammelin BR, Schiffman GL et al (2008) Safety of regadenoson, a selective adenosine A2A agonist, in patients with chronic obstructive pulmonary disease: a randomized, double-blind, placebo-controlled trial (RegCOPD trial). J Nucl Cardiol 15:319–328. doi:10.1016/j.nuclcard.2008.02.013

    Article  PubMed  Google Scholar 

  32. Pizzuto F, Voci P, Mariano E et al (2001) Assessment of flow velocity reserve by transthoracic Doppler echocardiography and venous adenosine infusion before and after left anterior descending coronary artery stenting. J Am Coll Cardiol 38:155–162

    Article  CAS  PubMed  Google Scholar 

  33. Wilson RF, Wyche K, Christensen BV, Zimmer S, Laxson DD (1990) Effects of adenosine on human coronary arterial circulation. Circulation 82:1595–1606

    Article  CAS  PubMed  Google Scholar 

  34. Tawa CB, Baker WB, Kleiman NS et al (1996) Comparison of adenosine echocardiography, with and without isometric handgrip, to exercise echocardiography in the detection of ischemia in patients with coronary artery disease. J Am Soc Echocardiogr 9:33–43

    Article  CAS  PubMed  Google Scholar 

  35. Miyazono Y, Kisanuki A, Toyonaga K et al (1998) Usefulness of adenosine triphosphate-atropine stress echocardiography for detecting coronary artery stenosis. Am J Cardiol 82:290–294

    Article  CAS  PubMed  Google Scholar 

  36. Porter TR, Adolphson M, High RR et al (2011) Rapid detection of coronary artery stenoses with real-time perfusion echocardiography during regadenoson stress. Circ Cardiovasc Imaging 4:628–635. doi:10.1161/CIRCIMAGING.111.966341

    Article  PubMed  Google Scholar 

  37. Leaker BR, O’Connor B, Hansel TT et al (2008) Safety of regadenoson, an adenosine A2A receptor agonist for myocardial perfusion imaging, in mild asthma and moderate asthma patients: a randomized, double-blind, placebo-controlled trial. J Nucl Cardiol 15:329–336. doi:10.1016/j.nuclcard.2008.02.009

    Article  PubMed  Google Scholar 

  38. Le DE, Bragadeesh T, Zhao Y, Wang YG, Zha D, Kaul S (2012) Detection of coronary stenosis with myocardial contrast echocardiography using regadenoson, a selective adenosine A2A receptor agonist. Eur Heart J Cardiovasc Imaging 13:298–308. doi:10.1093/ejechocard/jer232

    Article  PubMed  Google Scholar 

  39. Shaikh K, Wang DD, Saad H et al (2014) Feasibility, safety and accuracy of regadenoson-atropine (REGAT) stress echocardiography for the diagnosis of coronary artery disease: an angiographic correlative study. Int J Cardiovasc Imaging 30:515–522. doi:10.1007/s10554-014-0363-6

    Article  PubMed  Google Scholar 

  40. Hage FG (2014) Regadenoson for myocardial perfusion imaging: is it safe? J Nucl Cardiol 21:871–876. doi:10.1007/s12350-014-9922-4

    Article  PubMed  Google Scholar 

  41. Cerqueira MD, Verani MS, Schwaiger M, Heo J, Iskandrian AS (1994) Safety profile of adenosine stress perfusion imaging: results from the Adenoscan Multicenter Trial Registry. J Am Coll Cardiol 23:384–389

    Article  CAS  PubMed  Google Scholar 

  42. Lette J, Tatum JL, Fraser S et al (1995) Safety of dipyridamole testing in 73,806 patients: the Multicenter Dipyridamole Safety Study. J Nucl Cardiol 2:3–17

    Article  CAS  PubMed  Google Scholar 

  43. Picano E, Marini C, Pirelli S et al (1992) Safety of intravenous high-dose dipyridamole echocardiography. The Echo-Persantine International Cooperative Study Group. Am J Cardiol 70:252–258

    Article  CAS  PubMed  Google Scholar 

  44. Picano E, Mathias W Jr, Pingitore A, Bigi R, Previtali M (1994) Safety and tolerability of dobutamine-atropine stress echocardiography: a prospective, multicentre study. Echo Dobutamine International Cooperative Study Group. Lancet 344:1190–1192

    Article  CAS  PubMed  Google Scholar 

  45. Han PP, Tian YQ, Wei HX, Wang Q, He ZX (2011) Coronary spasm after completion of adenosine pharmacologic stress test. Ann Nucl Med 25:580–585. doi:10.1007/s12149-011-0493-z

    Article  PubMed  Google Scholar 

  46. Matsumoto N, Nagao K, Hirayama A, Kasama S (2014) Adenosine-induced coronary vasospasm following drug-eluting stent implantation. BMJ Case Rep. doi:10.1136/bcr-2013-202996

    Google Scholar 

  47. Communications FDs (2013) FDA warns of rare but serious risk of heart attack and death with cardiac nuclear stress test drugs Lexiscan (regadenoson) and Adenoscan (adenosine). Posted on 11/20/2013 www.fda.safety.alert for Human medical products.

  48. Patsilinakos SP, Kranidis AI, Antonelis IP et al (1999) Detection of coronary artery disease in patients with severe aortic stenosis with noninvasive methods. Angiology 50:309–317

    Article  CAS  PubMed  Google Scholar 

  49. Anthopoulos LP, Bonou MS, Kardaras FG et al (1996) Stress echocardiography in elderly patients with coronary artery disease: applicability, safety and prognostic value of dobutamine and adenosine echocardiography in elderly patients. J Am Coll Cardiol 28:52–59

    Article  CAS  PubMed  Google Scholar 

  50. Pellikka PA, Nagueh SF, Elhendy AA, Kuehl CA, Sawada SG (2007) American Society of Echocardiography recommendations for performance, interpretation, and application of stress echocardiography. J Am Soc Echocardiogr 20:1021–1041. doi:10.1016/j.echo.2007.07.003

    Article  PubMed  Google Scholar 

  51. Edlund A, Albertsson P, Caidahl K, Emanuelsson H, Wallentin I (1991) Adenosine infusion to patients with ischaemic heart disease may provoke left ventricular dysfunction detected by echocardiography. Clin Physiol 11:477–488

    Article  CAS  PubMed  Google Scholar 

  52. Martin TW, Seaworth JF, Johns JP, Pupa LE, Condos WR (1992) Comparison of adenosine, dipyridamole, and dobutamine in stress echocardiography. Ann Intern Med 116:190–196

    Article  CAS  PubMed  Google Scholar 

  53. Case RA, Buckmire R, McLaughlin DP, Keller M (1994) Physiological assessment of coronary artery disease and myocardial viability in ischemic syndromes using adenosine echocardiography. Echocardiography 11:133–143

    Article  CAS  PubMed  Google Scholar 

  54. Marwick T, Willemart B, D’Hondt AM et al (1993) Selection of the optimal nonexercise stress for the evaluation of ischemic regional myocardial dysfunction and malperfusion. Comparison of dobutamine and adenosine using echocardiography and 99mTc-MIBI single photon emission computed tomography. Circulation 87:345–354

    Article  CAS  PubMed  Google Scholar 

  55. Takeishi Y, Chiba J, Abe S, Yamaki M, Tomoike H (1994) Adenosine-induced heterogeneous perfusion accompanies myocardial ischemia in the presence of advanced coronary artery disease. Am Heart J 127:1262–1268

    Article  CAS  PubMed  Google Scholar 

  56. Djordjevic-Dikic A, Ostojic M, Beleslin B et al (2003) Low-dose adenosine stress echocardiography: detection of myocardial viability. Cardiovasc Ultrasound 1:7. doi:10.1186/1476-7120-1-7

    Article  PubMed Central  PubMed  Google Scholar 

  57. Heijenbrok-Kal MH, Fleischmann KE, Hunink MG (2007) Stress echocardiography, stress single-photon-emission computed tomography and electron beam computed tomography for the assessment of coronary artery disease: a meta-analysis of diagnostic performance. Am Heart J 154:415–423. doi:10.1016/j.ahj.2007.04.061

    Article  PubMed  Google Scholar 

  58. Amanullah AM, Bevegard S, Lindvall K, Aasa M (1993) Assessment of left ventricular wall motion in angina pectoris by two-dimensional echocardiography and myocardial perfusion by technetium-99m sestamibi tomography during adenosine-induced coronary vasodilation and comparison with coronary angiography. Am J Cardiol 72:983–989

    Article  CAS  PubMed  Google Scholar 

  59. Heinle S, Hanson M, Gracey L, Coleman E, Kisslo J (1993) Correlation of adenosine echocardiography and thallium scintigraphy. Am Heart J 125:1606–1613

    Article  CAS  PubMed  Google Scholar 

  60. Abdelmoneim SSMS (2009) Stress echocardiography-state of the art. US Cardiol 6(2):16–26

    Google Scholar 

  61. Moir S, Haluska BA, Jenkins C, Fathi R, Marwick TH (2004) Incremental benefit of myocardial contrast to combined dipyridamole-exercise stress echocardiography for the assessment of coronary artery disease. Circulation 110:1108–1113. doi:10.1161/01.CIR.0000139905.47128.9F

    Article  CAS  PubMed  Google Scholar 

  62. Tsutsui JM, Xie F, McGrain AC et al (2005) Comparison of low-mechanical index pulse sequence schemes for detecting myocardial perfusion abnormalities during vasodilator stress echocardiography. Am J Cardiol 95:565–570. doi:10.1016/j.amjcard.2004.10.035

    Article  PubMed  Google Scholar 

  63. Xie F, Hankins J, Mahrous HA, Porter TR (2007) Detection of coronary artery disease with a continuous infusion of definity ultrasound contrast during adenosine stress real time perfusion echocardiography. Echocardiography 24:1044–1050. doi:10.1111/j.1540-8175.2007.00543.x

    Article  PubMed  Google Scholar 

  64. Abdelmoneim SS, Bernier M, Dhoble A et al (2010) Diagnostic accuracy of contrast echocardiography during adenosine stress for detection of abnormal myocardial perfusion: a prospective comparison with technetium-99 m sestamibi single-photon emission computed tomography. Heart Vessels 25:121–130. doi:10.1007/s00380-009-1174-x

    Article  PubMed  Google Scholar 

  65. Arnold JR, Karamitsos TD, Pegg TJ et al (2010) Adenosine stress myocardial contrast echocardiography for the detection of coronary artery disease: a comparison with coronary angiography and cardiac magnetic resonance. JACC Cardiovasc Imaging 3:934–943. doi:10.1016/j.jcmg.2010.06.011

    Article  PubMed  Google Scholar 

  66. Korosoglou G, Da Silva KG Jr, Labadze N, Dubart AE et al (2004) Real-time myocardial contrast echocardiography for pharmacologic stress testing: is quantitative estimation of myocardial blood flow reserve necessary? J Am Soc Echocardiogr 17:1–9. doi:10.1016/j.echo.2003.08.004

    Article  PubMed  Google Scholar 

  67. Malm S, Frigstad S, Torp H, Wiseth R, Skjarpe T (2006) Quantitative adenosine real-time myocardial contrast echocardiography for detection of angiographically significant coronary artery disease. J Am Soc Echocardiogr 19:365–372. doi:10.1016/j.echo.2005.10.026

    Article  PubMed  Google Scholar 

  68. Kowatsch I, Tsutsui JM, Osorio AF et al (2007) Head-to-head comparison of dobutamine and adenosine stress real-time myocardial perfusion echocardiography for the detection of coronary artery disease. J Am Soc Echocardiogr 20:1109–1117. doi:10.1016/j.echo.2007.02.008

    Article  PubMed  Google Scholar 

  69. Osorio AF, Tsutsui JM, Kowatsch I et al (2007) Evaluation of blood flow reserve in left anterior descending coronary artery territory by quantitative myocardial contrast and Doppler echocardiography. J Am Soc Echocardiogr 20:709–716. doi:10.1016/j.echo.2006.11.016

    Article  PubMed  Google Scholar 

  70. Vogel R, Indermuhle A, Meier P, Seiler C (2009) Quantitative stress echocardiography in coronary artery disease using contrast-based myocardial blood flow measurements: prospective comparison with coronary angiography. Heart 95:377–384. doi:10.1136/hrt.2007.134577

    Article  CAS  PubMed  Google Scholar 

  71. Hachamovitch R, Hayes SW, Friedman JD, Cohen I, Berman DS (2005) A prognostic score for prediction of cardiac mortality risk after adenosine stress myocardial perfusion scintigraphy. J Am Coll Cardiol 45:722–729. doi:10.1016/j.jacc.2004.08.069

    Article  PubMed  Google Scholar 

  72. Jahnke C, Nagel E, Gebker R et al (2007) Prognostic value of cardiac magnetic resonance stress tests: adenosine stress perfusion and dobutamine stress wall motion imaging. Circulation 115:1769–1776. doi:10.1161/CIRCULATIONAHA.106.652016

    Article  PubMed  Google Scholar 

  73. Ren L, Liu Y, Lin J, Ye H, Wang P (2013) Application of adenosine stress echocardiography in the prognosis of acute myocardial infarction following percutaneous coronary interventional therapy. Exp Ther Med 6:727–730. doi:10.3892/etm.2013.1193

    PubMed Central  PubMed  Google Scholar 

  74. Kawata T, Daimon M, Hasegawa R et al (2013) Prognostic value of coronary flow reserve assessed by transthoracic Doppler echocardiography on long-term outcome in asymptomatic patients with type 2 diabetes without overt coronary artery disease. Cardiovasc Diabetol 12:121. doi:10.1186/1475-2840-12-121

    Article  PubMed Central  PubMed  Google Scholar 

  75. Tsutsui JM, Elhendy A, Anderson JR et al (2005) Prognostic value of dobutamine stress myocardial contrast perfusion echocardiography. Circulation 112:1444–1450. doi:10.1161/CIRCULATIONAHA.105.537134

    Article  PubMed  Google Scholar 

  76. Dawson D, Kaul S, Peters D et al (2009) Prognostic value of dipyridamole stress myocardial contrast echocardiography: comparison with single photon emission computed tomography. J Am Soc Echocardiogr 22:954–960. doi:10.1016/j.echo.2009.04.034

    Article  PubMed Central  PubMed  Google Scholar 

  77. Mattoso AA, Kowatsch I, Tsutsui JM et al (2013) Prognostic value of qualitative and quantitative vasodilator stress myocardial perfusion echocardiography in patients with known or suspected coronary artery disease. J Am Soc Echocardiogr 26:539–547. doi:10.1016/j.echo.2013.01.016

    Article  PubMed  Google Scholar 

  78. Nhola LAS, Huang R, Kirby BG et al (2014) Quantitative assessment of myocardial blood flow reserve using definity during Regadenoson vasodilator stress real-time myocardial contrast echocardiography for detection of left anterior descending coronary artery stenosis. J Am Coll Cardiol 63(12 Suppl 1):.A1235

    Google Scholar 

  79. Reddy PCC, Ahlberg AW, Aoun G et al (2002) Cost-effectiveness of adenosine and dipyridamole in technetium-99m sestamibi single photon computed tomography imaging. Value Health 5:128

    Article  Google Scholar 

  80. Montalescot G, Sechtem U, Achenbach S et al (2013) 2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J 34:2949–3003. doi:10.1093/eurheartj/eht296

    Article  PubMed  Google Scholar 

  81. Wolk MJ, Bailey SR, Doherty JU et al (2014) ACCF/AHA/ASE/ASNC/HFSA/HRS/SCAI/SCCT/SCMR/STS 2013 multimodality appropriate use criteria for the detection and risk assessment of stable ischemic heart disease: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, and Society of Thoracic Surgeons. J Card Fail 20:65–90. doi:10.1016/j.cardfail.2013.12.002

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Preventive Cardiology, Women’s Heart Clinic, Mayo Clinic and College of Medicine, Rochester, MN, USA

    Sharon L. Mulvagh MD, FACC, FAHA, FASE, FRCP(C)

  2. Mayo Clinic, Rochester, MN, USA

    Sahar S. Abdelmoneim MBBCH, MSc, MS

  3. CNR Pisa Ist. Fisiologia Clinica, Via Moruzzi 1, Pisa, 56124, Italy

    Eugenio Picano MD, PhD

Authors
  1. Sharon L. Mulvagh MD, FACC, FAHA, FASE, FRCP(C)
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sahar S. Abdelmoneim MBBCH, MSc, MS
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Eugenio Picano MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Table of Contents Video Companion

Table of Contents Video Companion

  • See also in the section “Illustrative cases: case numbers 17 and 18” (by Prof Ana Djordjevic-Dikic).

  • See also in the section “Selected presentations: Pharmacological and myocardial effects of adenosine and dipyridamole.”

  • Springer Extra Materials available at http://extras.springer.com/2015/978-3-319-20957-9

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer International Publishing

About this chapter

Cite this chapter

Mulvagh, S.L., Abdelmoneim, S.S., Picano, E. (2015). Adenosine and Regadenoson Stress Echocardiography. In: Stress Echocardiography. Springer, Cham. https://doi.org/10.1007/978-3-319-20958-6_14

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-20958-6_14

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-20957-9

  • Online ISBN: 978-3-319-20958-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation